Pregabalin in Treating Women With Hot Flashes
Study Information
Alliance Study ID: NCCTG-N07C1
NCT Study ID (ClinicalTrials.gov): NCT00702949
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Charles Loprinzi, MD
Status: COMPLETED
Study Description
RATIONALE: Pregabalin may help relieve hot flashes in women with a history of breast cancer or those who have no history and do not wish to take estrogen therapy for fear of increased risk of breast cancer. It is not yet known what dose of pregabalin may be more effective in treating hot flashes.
PURPOSE: This is a randomized phase III trial to determine the efficacy of two doses of pregabalin, in comparison to placebo, in the prevention of hot flashes.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information